TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 25 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $43,000 | -34.8% | 97,673 | 0.0% | 0.00% | – |
Q2 2019 | $66,000 | -15.4% | 97,673 | +71.4% | 0.00% | – |
Q1 2019 | $78,000 | +11.4% | 56,974 | -50.0% | 0.00% | – |
Q4 2018 | $70,000 | -39.7% | 113,948 | +100.0% | 0.00% | – |
Q3 2018 | $116,000 | -24.2% | 56,974 | 0.0% | 0.00% | – |
Q2 2018 | $153,000 | +146.8% | 56,974 | +110.6% | 0.00% | – |
Q1 2018 | $62,000 | -31.1% | 27,057 | 0.0% | 0.00% | – |
Q4 2017 | $90,000 | +5.9% | 27,057 | 0.0% | 0.00% | – |
Q3 2017 | $85,000 | +32.8% | 27,057 | 0.0% | 0.00% | – |
Q2 2017 | $64,000 | -40.2% | 27,057 | -5.8% | 0.00% | – |
Q1 2017 | $107,000 | -23.0% | 28,710 | +0.8% | 0.00% | – |
Q4 2016 | $139,000 | -15.8% | 28,488 | +16.5% | 0.00% | – |
Q3 2016 | $165,000 | +55.7% | 24,457 | +0.2% | 0.00% | – |
Q2 2016 | $106,000 | -37.6% | 24,420 | 0.0% | 0.00% | – |
Q1 2016 | $170,000 | -24.4% | 24,420 | -0.2% | 0.00% | – |
Q4 2015 | $225,000 | +17.8% | 24,457 | +24.6% | 0.00% | – |
Q3 2015 | $191,000 | -8.2% | 19,626 | +6.6% | 0.00% | – |
Q2 2015 | $208,000 | – | 18,417 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 1,889,652 | $18,462,000 | 1.22% |
WALL STREET ASSOCIATES | 250,000 | $2,442,000 | 0.47% |
Eventide Asset Management | 403,912 | $3,946,000 | 0.23% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $4,738,000 | 0.18% |
J. Goldman & Co LP | 170,000 | $1,661,000 | 0.14% |
QVT Financial LP | 363,292 | $3,549,000 | 0.12% |
Kinsight, LLC | 10,053 | $98,000 | 0.07% |
Welch Group, LLC | 33,769 | $330,000 | 0.06% |
Visium Asset Management, LP | 436,336 | $4,263,000 | 0.06% |
Candriam S.C.A. | 135,300 | $1,322,000 | 0.03% |